Unisafe®️ 2.25: Seamlessly Transitioning To New-Generation Biologics

With a readership of over 40,000, ONdrugDelivery Magazine is the highly regarded drug delivery publication which shares contributions from world experts at leading companies in the global drug delivery business.

As new-generation biologics increase in volume and viscosity, developers of drug delivery devices must revisit previous designs to accommodate new formulations.

If these drugs could be subcutaneously administered, this would help to alleviate some of the pressure on healthcare systems, as this route is more suitable for home administration than intravenous drug delivery.

However, to ensure effective administration outside of a healthcare setting, it is critical that manufacturers develop drug delivery solutions with the needs of patients and carers in mind, as well as healthcare professionals.

In this article, George I’ons discusses the benefits of subcutaneously administering new drug formulations, and the factors that manufacturers need to consider when designing delivery devices.